These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 20179125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
    Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A.
    BMJ; 2004 May 29; 328(7451):1293. PubMed ID: 15166066
    [Abstract] [Full Text] [Related]

  • 4. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, Chan KK, Ngan HY.
    Acta Obstet Gynecol Scand; 2011 May 29; 90(5):445-51. PubMed ID: 21306349
    [Abstract] [Full Text] [Related]

  • 5. Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country.
    Garcés-Palacio IC, Sanchez GI, Baena Zapata A, Córdoba Sánchez V, Urrea Cosme Y, Rodríguez Zabala D, Ruiz Osorio MA.
    Psychol Health; 2020 Jun 29; 35(6):750-769. PubMed ID: 31625399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The psychosocial impact of an abnormal cervical smear result.
    Drolet M, Brisson M, Maunsell E, Franco EL, Coutlée F, Ferenczy A, Fisher W, Mansi JA.
    Psychooncology; 2012 Oct 29; 21(10):1071-81. PubMed ID: 21695747
    [Abstract] [Full Text] [Related]

  • 8. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
    Bennett KF, Waller J, McBride E, Forster AS, Di Gessa G, Kitchener H, Marlow L.
    BJOG; 2021 Mar 29; 128(4):745-754. PubMed ID: 32783300
    [Abstract] [Full Text] [Related]

  • 9. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
    McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J.
    BJOG; 2004 Dec 29; 111(12):1437-43. PubMed ID: 15663132
    [Abstract] [Full Text] [Related]

  • 10. The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.
    Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P.
    Int J Gynecol Cancer; 2008 Dec 29; 18(4):743-8. PubMed ID: 17944916
    [Abstract] [Full Text] [Related]

  • 11. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
    McBride E, Marlow LAV, Forster AS, Ridout D, Kitchener H, Patnick J, Waller J.
    Int J Cancer; 2020 Apr 15; 146(8):2113-2121. PubMed ID: 31251820
    [Abstract] [Full Text] [Related]

  • 12. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D, Moore Simas TA, Reynolds M, Melnitsky H.
    J Low Genit Tract Dis; 2009 Apr 15; 13(2):66-71. PubMed ID: 19387125
    [Abstract] [Full Text] [Related]

  • 13. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
    Howard K, Salkeld G, McCaffery K, Irwig L.
    Health Econ; 2008 May 15; 17(5):593-605. PubMed ID: 17764095
    [Abstract] [Full Text] [Related]

  • 14. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C, Karlsson H, Spetz Holm AC.
    PLoS One; 2020 May 15; 15(7):e0235202. PubMed ID: 32614875
    [Abstract] [Full Text] [Related]

  • 15. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T, Hicks W, Menard C, Boyd D, Hewson T, Hopkins L, Kee Fung MF.
    J Obstet Gynaecol Can; 2004 Sep 15; 26(9):788-92. PubMed ID: 15361273
    [Abstract] [Full Text] [Related]

  • 16. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
    Wen KY, Dayaratna S, Slamon R, Granda-Cameron C, Tagai EK, Kohler RE, Hudson SV, Miller SM.
    Transl Behav Med; 2024 Jan 11; 14(1):1-12. PubMed ID: 38014626
    [Abstract] [Full Text] [Related]

  • 17. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K, Irwig L.
    J Med Screen; 2005 Jan 11; 12(3):134-41. PubMed ID: 16156944
    [Abstract] [Full Text] [Related]

  • 18. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
    McBride E, Marlow L, Forster AS, Moss S, Myles J, Kitchener H, Patnick J, Waller J.
    BMJ Open; 2016 Dec 23; 6(12):e014356. PubMed ID: 28011816
    [Abstract] [Full Text] [Related]

  • 19. Determining the impact of informed choice: separating treatment effects from the effects of choice and selection in randomized trials.
    McCaffery KJ, Turner R, Macaskill P, Walter SD, Chan SF, Irwig L.
    Med Decis Making; 2011 Dec 23; 31(2):229-36. PubMed ID: 21041538
    [Abstract] [Full Text] [Related]

  • 20. Swedish women's awareness of human papillomavirus, and health-related quality of life, anxiety, and depression after a notification of an abnormal Pap smear result: a cross-sectional study.
    Rask M, Swahnberg K, Oscarsson M.
    Eur J Cancer Prev; 2019 Mar 23; 28(2):96-101. PubMed ID: 29406336
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.